SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : LIPO-Liposome
LIPO 0.411+17.4%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Beltropolis Boy who wrote (642)12/22/1998 11:22:00 AM
From: MoneyMade  Read Replies (1) of 900
 
LIPO---News Liposome Co. (LIPO) 9 13/16 +13/16: Hambrecht & Quist upgrades drug developer from "hold" to "buy" based on resolution of the uncertainties regarding new Abelcet competitors and launch of Evacet; expects Evacet launch in the fall of 1999, while Abelcet sales have continued to grow; raises Q4 EPS estimate from loss of $0.02 to net of $0.01 a share; has a price target in the range of $25-$30 a share.....





M$ney
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext